Chandan Healthcare Ltd (CHANDAN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Chandan Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Monitoring Agency Report for the quarter ended September 30, 2026.
Others (Uncategorized) · 30 Oct 2026, 9:31 pm
Chandan Healthcare Preferential Issue Monitoring Report for Sep'26 Quarter Crisil Ratings confirmed no deviation or implementation delays in Chandan Healthcare's ₹104.13 Cr preferential issue of fully convertible warrants as of 30th Sep'26. Out of ₹47.97 Cr received proceeds, the company deployed ₹8.39 Cr during the quarter toward business expansion, bringing total utilization to ₹36.52 Cr (₹31.76 Cr for expansion, ₹4.76 Cr for general corporate purposes). Unutilized funds stand at ₹11.45 Cr, held in ICICI Bank monitoring and fixed deposit accounts. A remaining ₹56.16 Cr is receivable upon warrant conversions due by 28th Jul'27.
Chandan Healthcare Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on November 20, 2026
Annual General Meeting · 28 Oct 2026, 9:14 pm
Chandan Healthcare Convenes EGM for Related Party Guarantees and Transactions Chandan Healthcare Limited has scheduled an Extraordinary General Meeting on 20th Nov'26 to seek shareholder approval for key related party transactions valid up to 19th Nov'27. Key proposals include availing personal guarantees of up to Rs 85 crore each from promoter-directors and relatives (Mr. Amar Singh, Mrs. Asmita Singh, Mr. Vinay Lamba, Mrs. Aasti Singh, and Mr. Anant Singh) without commission. Additionally, approvals are sought for diagnostic services and goods transactions with entities including Chandan Hospital (up to Rs 13.04 crore) and Chandan Super Speciality Hospital (up to Rs 11 crore).
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 14 Oct 2026, 12:04 am
Chandan Healthcare Q2 FY27 Diagnostics Revenue Surges 46.66% YoY Chandan Healthcare reported provisional Q2 FY27 diagnostics revenue growth of 46.66% YoY to Rs. 5,637.88 lakhs, compared to Rs. 3,844.29 lakhs in Q2 FY26. Total income jumped 73.22% YoY to Rs. 7,103.26 lakhs, supported by Rs. 1,465.38 lakhs in other income, which includes a one-time gain of Rs. 1,203.00 lakhs from selling equity shares in Chandan Pharmacy Limited. Excluding one-off income, total income grew 43.89% YoY to Rs. 5,900.26 lakhs. The company expanded aggressively, adding 410 franchises during the quarter to reach a total network of 685 franchises, alongside 25 comprehensive diagnostic centres, 19 diagnostic centres, 25 diagnostic labs, and 16 radiology labs as of 30th Sep'26.
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 07 Oct 2026, 4:40 pm
Chandan Healthcare Announces Resignation of Independent Director Vinod Jain Mr. Vinod Jain has resigned from his position as Independent Director of Chandan Healthcare Limited, effective 5th Oct'26, citing increased time commitments required by other professional obligations. He confirmed there are no material reasons or disagreements with the board or management concerning his departure. Jain holds no other directorships or board committee memberships in listed entities. Chandan Healthcare confirmed that post-resignation board composition continues to comply with the minimum Independent Director requirements under SEBI LODR Regulations.
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 07 Oct 2026, 12:15 am
Chandan Healthcare Secures ₹5.22 Crore Loan from ICICI Bank for CT Scanner Capex ICICI Bank sanctioned a ₹5.22 crore Medical Equipment Loan facility to Chandan Healthcare on 5th Oct'26 to fund the procurement of a 128-slice CT scanner costing ₹5.80 crore. The bank will fund 90% of the asset cost, with the company contributing a 10% margin. The facility carries an interest rate of 8.75% p.a. over a 60-month tenure, including a 60-day moratorium, secured by asset hypothecation. The capex will support ordinary business expansion with zero impact on management control.
Chandan Healthcare Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 06 Oct 2026, 11:58 pm
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 06 Oct 2026, 11:47 pm
Chandan Healthcare Independent Director Vinod Jain Resigns Citing Professional Commitments Chandan Healthcare Limited announced that Independent Director Mr. Vinod Jain resigned effective 5th Oct'26, citing other professional commitments requiring his increased time and attention. Appointed on 13th Aug'26, Mr. Jain confirmed there are no material reasons or disagreements with the board or management regarding his departure. He holds no directorships or committee memberships in other listed entities. Following the resignation, the company confirmed that the board's composition continues to comply with the minimum independent director requirements under SEBI LODR Regulations.
Chandan Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 5:01 pm
Chandan Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 11:50 pm
Chandan Healthcare Limited has informed regarding Disclosure of material issue
Others (Uncategorized) · 30 Sept 2026, 11:41 pm
Chandan Healthcare Allots Equity Shares on Preferential Warrant Conversion Chandan Healthcare approved the allotment of 6,50,000 equity shares of ₹10 face value at ₹234 per share (including ₹224 premium) on 30th Sep'26, aggregating ₹15.21 crore upon converting preferential warrants. Allotted to non-promoter entities Negen Capital Services (2,50,000 shares; 0.97%) and Negen Undiscovered Value Fund (4,00,000 shares; 1.56%), total paid-up equity capital increased from ₹25.05 crore to ₹25.70 crore across 2,57,02,062 shares. Management control remains unchanged, with 32,00,002 warrants outstanding.
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 26 Sept 2026, 12:15 am
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 25 Sept 2026, 7:57 pm
Chandan Healthcare Expands Integrated Diagnostic Network and Diagnostic Presence Chandan Healthcare delivered robust Q1FY27 performance, reporting revenue of ₹92.25 crore, EBITDA of ₹20.98 crore (22.75% margin), and PAT of ₹7.50 crore (8.13% margin). In FY26, revenue reached ₹270.39 crore with an EBITDA margin of 20.25%, driven by B2C retail (41.50% share, up 29.57% YoY), B2G government partnerships (31.82% share), and B2B institutional segments (26.68% share, up 50.58% YoY). Over the next three years, the company plans to add 40 comprehensive diagnostic centres, 50 diagnostic centres, 50 standalone laboratories, and over 5,000 franchise centres across 17 states.
Chandan Healthcare Limited has informed the Exchange about Cancellation
Intimation · 25 Sept 2026, 4:16 pm
Chandan Healthcare Cancels Investor Meeting Scheduled for September 2026 Chandan Healthcare Limited announced the cancellation of its virtual institutional investor/analyst meet scheduled for 25th Sep'26 at 01:00 PM onwards due to unavoidable circumstances. The meeting was originally slated to take place as part of the Bharat Connect Conference organized by Arihant Capital, following an earlier intimation on 22nd Sep'26 pursuant to SEBI Listing Regulations.
Chandan Healthcare Limited has informed the Exchange about General Updates
Others (Uncategorized) · 23 Sept 2026, 7:51 pm
Chandan Healthcare Crosses 500 Franchise Centres; Targets 1,000 by FY27-End Chandan Healthcare expanded its diagnostic franchise network to over 500 operational centres as of 15th Sep'26, taking its overall network to 568+ centres. Operating an asset-light, zero-capex franchise model where partners fund local infrastructure and operating expenses, the company plans to reach 1,000 franchise centres by FY27-end and 3,000 centres over the subsequent two years. Currently, ~80% of franchises are concentrated in Uttar Pradesh, with plans to expand pan-India. In FY26, the company posted consolidated total income of ₹280.67 Cr, EBITDA of ₹56.84 Cr, and PAT of ₹27.06 Cr.
Chandan Healthcare Limited has informed the Exchange about Schedule of meet
Intimation · 22 Sept 2026, 5:47 pm
Chandan Healthcare Schedules Institutional Investor Meeting on 25th Sep'26 Chandan Healthcare Limited will participate in an institutional investor and analyst meet on 25th Sep'26 from 01:00 PM onwards. Company officials are scheduled to attend the Bharat Connect Conference organized by Arihant Capital via a virtual platform. Management confirmed that discussions will rely exclusively on publicly available information, with no unpublished price-sensitive information (UPSI) being shared.
The Exchange had sought clarification from Chandan Healthcare Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Others (Uncategorized) · 15 Sept 2026, 8:31 pm
Chandan Healthcare Clarifies Single Reportable Operating Segment to NSE Chandan Healthcare Limited responded on 3rd Sep'26 to NSE queries regarding the absence of segment reporting in its financial results submitted on 14th Aug'26 for the quarter ended 30th Jun'26. The company clarified that it operates exclusively within a single reportable business segment comprising healthcare and diagnostic services. Consequently, under SEBI LODR regulations, separate segment-wise financial disclosures are not applicable or required.
Chandan Healthcare Limited has informed regarding allotment of 5,99,998 equity shares upon conversion of fully convertible warrants issued on a preferential basis.
Others (Uncategorized) · 15 Sept 2026, 12:09 am
Chandan Healthcare Allots 5.99 Lakh Shares Post Warrant Conversion for ₹14.04 Crore On 14th Sep'26, Chandan Healthcare Limited approved the preferential allotment of 5,99,998 equity shares of ₹10 face value at ₹234 per share (including ₹224 premium), aggregating ₹14.04 crore, upon conversion of warrants to five non-promoter public investors. Jeena Sikho Lifecare received 4,50,000 shares (1.80% stake) and Compact Structure Fund received 1,16,666 shares (0.47% stake). Paid-up capital increased from ₹24.45 crore (2.45 crore shares) to ₹25.05 crore (2.51 crore shares), leaving 38,50,002 warrants outstanding with no change in management control.
Chandan Healthcare Limited has informed the Exchange about Outcome
Others · 11 Sept 2026, 10:24 pm
Chandan Healthcare Concludes Analyst and Investor Interaction Meeting Chandan Healthcare Limited conducted its scheduled virtual analysts and investors meeting on 11th Sep'26. The interaction included multiple institutional participants such as Dolat Capital, Valentis Advisors, Wealth with Wisdom, White Bridge Capital, Vinamra Capital Services LLP, 3 Head Capital, 1729 Growth Fund, SM Holdings, Perpetuity Ventures LLP, and HNI investors. The session was conducted in a Q&A format without any formal corporate presentation, and no unpublished price-sensitive information was disclosed.
Chandan Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 08 Sept 2026, 12:03 am
Chandan Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
Outcome · 07 Sept 2026, 10:11 pm
Chandan Healthcare Board Reallocates Rs 50 Crore Warrant Proceeds for Organic Expansion Chandan Healthcare's Board recommended reallocating Rs 50,00,00,000 of unutilised proceeds from its 44,50,000 preferential convertible warrants issue approved on 6th Nov'25. The funds, originally earmarked for acquiring existing diagnostic centres, units, and equipment, will now be deployed organically to set up new diagnostic laboratories and comprehensive diagnostic centres. The Board also recommended appointing Sanjay Srivastava as an Independent Director for a five-year term from 30th Sep'26 to 29th Sep'31, alongside ratifying Cost Auditor remuneration for FY 2026-27, subject to shareholder approval.
Chandan Healthcare Limited has informed the Exchange about Schedule of meet
Intimation · 07 Sept 2026, 9:07 pm
Chandan Healthcare Schedules Virtual Investor Meeting on 11th Sep'26 Chandan Healthcare Limited has scheduled a virtual investor and analyst group meeting for 11th Sep'26 at 01:00 PM IST, organized by Kirin Advisors. The intimation is filed under Regulation 30 of SEBI (LODR) Regulations, 2015, and the details are accessible on the company's official website.
The Exchange has sought clarification from Chandan Healthcare Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Others (Uncategorized) · 02 Sept 2026, 7:45 pm
Chandan Healthcare Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on August 29, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 31 Aug 2026, 9:30 pm
Chandan Healthcare Shareholders Approve Divestment of Pharmacy Subsidiary Chandan Healthcare shareholders approved the disinvestment of its entire stake in subsidiary Chandan Pharmacy Limited via a special resolution at the EGM on 29 Aug'26. The resolution passed with an overwhelming 99.90% of valid votes in favour. Promoter group voting was 100% in favour. This approval paves the way for the company to proceed with the strategic sale of its pharmacy business unit. Only 0.10% of total valid votes were cast against the proposal.
Chandan Healthcare Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on August 29, 2026
Annual General Meeting · 29 Aug 2026, 10:13 pm
Chandan Healthcare to Divest Entire Stake in Pharmacy Subsidiary Chandan Healthcare held an EGM on 29 Aug'26 to approve the disinvestment of its entire 53.56% stake in subsidiary Chandan Pharmacy Limited (CPL). The transaction, valued at approximately ₹16.77 crore, will be sold to group company Chandan Hospital Limited. The divestment enables a strategic realignment to focus on core, higher-growth operations and unlock value. Proceeds will fund capital expenditure for expansion projects. Upon completion, CHL's holding will reduce to nil, and CPL will cease to be a subsidiary of the company.
Chandan Healthcare Limited has informed the Exchange about Transcript
Transcript · 20 Aug 2026, 9:53 pm
Chandan Healthcare Q1 FY27: Divestment and Franchise-Led Growth Shape New Strategy Chandan Healthcare reported Q1 FY27 consolidated sales of INR82.26 crore (+19.62% YoY) and PAT of INR7.5 crore (+29% YoY). The company divested its pharmacy business for INR16.77 crore to focus on the higher-margin diagnostics segment. Management provided aggressive guidance, targeting over 50% YoY revenue growth for the next three years, driven by a capital-light franchise model. The goal is to scale from 327 centers to 1,000 franchises this fiscal year. Standalone diagnostics EBITDA margin reached 36.57%, with a near-term target of 40%.